Pulmonary Infiltrates in the Non-HIV-Infected Immunocompromised Patient: Etiologies, Diagnostic Strategies, and Outcomes

Chest

Volumn 125, Issue 1, 2004, Pages 260-271

  Shorr, Andrew F ^a   Susla, Gregory M ^b   O'Grady, Naomi P ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Bronchoscopy; Complications; Fungus; Immunocompromised; Infection; Infiltrates; Malignancy; Outcomes; Transplant

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BLEOMYCIN; BUSULFAN; CARMUSTINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOXORUBICIN; FLUDARABINE; GEMCITABINE; INTERLEUKIN 2; LOMUSTINE; METHOTREXATE; MITOMYCIN; PROCARBAZINE; RAPAMYCIN; TAXANE DERIVATIVE; THYMOCYTE ANTIBODY; VINCA ALKALOID;

ANAMNESIS; ANTIBIOTIC THERAPY; BACTERIUM; BLOOD CULTURE; BRONCHOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FUNGUS; HUMAN; IMMUNE DEFICIENCY; LUNG EDEMA; LUNG INFECTION; LUNG INFILTRATE; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; THORAX RADIOGRAPHY; VIRUS;

EID: 1642493878     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.1.260     Document Type: Review

References (58)

1. Shorr AF, Moores LK, Edenfield WJ, et al. Mechanical ventilation in hematopoietic stem cell transplantation: can we effectively predict outcomes? Chest 1999; 116:1012-1018
2. White P. Evaluation of pulmonary infiltrates in critically ill patients with cancer and marrow transplant. Crit Care Clin 2001; 17:647-670
3. Rano A, Agusti C, Jimenez P, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using noninvasive and bronchoscopic procedures. Thorax 2001; 56:379-387
4. Torres A, Ewing S, Insausti J, et al. Etiology and microbial patterns of pulmonary infiltrates in patients with orthotopic liver transplantation. Chest 2000; 117:494-502
5. Knirsch CA, Jakon K, Schoonmaker MS, et al. An outbreak of Legionella pneumonia in transplant patients: evaluation, molecular epidemiology, and control. Am J Med 2000; 108:290-295
6. Paterson DL, Singh N. Invasive Aspergillosis in transplant recipients. Medicine 1999; 78:123-138
7. Marr KA, Carter RA, Crippa F, et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34:909-917
8. Jantunen E, Ruutu P, Niskanen L, et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997; 19:801-808
9. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19:253-259
10. Patterson TF, Kirkpatrick WR, White M, et al. Invasive Aspergillosis: disease spectrum, treatment practices, and outcomes. Medicine 2000; 79:250-260
11. Wingard JR. Opportunistic infections after blood and marrow transplantation. Transpl Infect Dis 1999; 1:3-20
12. Maartens J, Vehaegen J, Lagrow K, et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive Aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97:1604-1610
13. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20:1898-1906
14. Haron E, Vartivarian S, Anaissie E, et al. Primary Candida pneumonia: experience at a large cancer center and review of the literature. Medicine 1993; 72:137-142
15. Harnacher J, Spiliopoulous A, Kurt AM, et al. Pre-emptive therapy with azoles in lung transplant patients: Geneva Lung Transplantation Group. Eur Respir J 1999; 13:180-186
16. Wendt CH. Community respiratory viruses: organ transplant recipients. Am J Med 1997; 102:31-36
17. Goodrich J. A comparison of cytomegalovirus and community respiratory viruses in immunocompromised patients. Am J Med 1997; 102:37-41
18. Sternberg RI, Baugman RP, Dohn MN, et al. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients. Am J Med 1993; 95:358-364
19. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients widiout acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996; 71:5-13
20. Byrd JC, Hargis JB, Rester KE, et al. Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis. Am J Hematol 1995; 49:135-142
21. Thomas CF, Limper AH. Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome. Semin Respir Infect 1998; 13:289-295
22. Limper AH, Offord KP, Smith TF, et al. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989; 140:1204-1209
23. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997; 19:467-470
24. Singli N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27:1266-1277
25. Crawford SW. Noninfectious lung disease in the immunocompromised host. Respiration 1999; 66:385-395
26. Kurshid I, Anderson LC. Noninfectious pulmonary complications after bone marrow transplantation. Postgrad Med J 2002; 78:257-262
27. Briasoulis E, Pavlidis N. Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy. Oncologist 2001; 6:153-161
28. Masson RG, Kirkorian J, Lukl P, et al. Pulmonary microvascular cytology in the diagnosis of lymphangitic carcinomatosis. N Engl J Med 1989; 321:71-76
29. Savage P, Waxman J. Post-transplantation lymphoproliferative disease. QJM 1997; 90:497-503
30. Preiksaitis JK. Epstein-Barr virus infection and malignancy in solid organ transplant recipients: strategies for prevention and treatment. Transpl Infect Dis 2001; 3:56-59
31. Tanner JE, Alfieri C. The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transpl Infect Dis 2001; 3:60-69
32. Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94:2208-2216
33. Rossi SE, Erasmus JJ, McAdams HP, et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000; 20:124.5-1259
34. Shorr AF, Abbott KC, Agadoa LY. Acute respiratory distress syndrome following renal transplantation: epidemiology, risk factors, and outcomes. Crit Care Med 2003; 31:1325-1330
35. Dimopoulou I, Galani H, Dafni U, et al. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin. Cancer 2002; 94:452-458
36. Helman DL, Byrd JC, Ales NC, et al. Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes. Chest 2002; 122:785-790
37. Morelon E, Stern M, Israel-Beit D, et al. Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation 2001; 72:787-790
38. Arbetter KR, Prakash UB, Tazelaar HD, et al. Radiation-induced pneumonitis in die "nonirradiated" lung. Mayo Clin Proc 1999; 74:27-36
39. Afessa B, Tefferi A, Litzow MR, et al. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002; 166:641-745
40. DeLassence A, Fleury-Fieth J, Escudier E, et al. Alveolar hemorrhage: diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 1995; 151:157-163
41. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27:893-898
42. Marr KA, Patterson T, Denning D. Aspergillosis: pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002; 16:875-894
43. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992; 14:1201-1207
44. Abbas J, Bodey GP, Hanna HA, et al. Candida krusei fungemia: an escalating serious infection in inimunocompromised patients. Arch Intern Med 2000; 160:2659-2664
45. Sepkowitz KA. Antibiotic prophylaxis in patients receiving hematopoietic stem cell transplant. Bone Marrow Transplant 2002; 29:367-371
46. Heussel CP, Kauczor HU, Heussel G, et al. Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. AJR Am J Roentgenol 1997; 169:1347-1353
47. Gulati M, Kaur R, Jha V, et al. High-resolution CT in renal transplant patients with suspected pulmonary infections. Acta Radiol 2000; 41:237-241
48. Heussel CP, Kauczor HU, Heussel GE, et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 1999; 17:796-805
49. Nusair S, Kramer MR. The role of fibre-optic bronchoscopy in solid organ, transplant patients with pulmonary infections. Respir Med 1999; 93:621-629
50. Murray PV, O'Brien ME, Padhani AR, et al. Use of first line bronchoalveolar lavage in the immunosuppressed oncology patient. Bone Marrow Transplant 2001; 27:967-971
51. Rano A, Agusti C, Banito N, et al. Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2002; 122:253-261
52. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262-268
53. White DA, Wong PW, Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 2002; 161:723-729
54. Weill D, McGriffin DC, Zorn GL, et al. The utility of open lung biopsy following lung transplantation. J Heart Lung Transplant 2000; 19:852-857
55. Duran FG, Piqueras B, Romero M, et al. Pulmonary complications following orthotopic liver transplant. Transpl Int 1998; 11(Suppl 1):S255-S259
56. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-155
57. Antonelli M, Conti G, Maurizio B, et al. Noninvasive ventilation for treatment of acute respirator failure in patients undergoing solid organ transplantation: a randomized trial. JAMA 2000; 283:23.5-241
58. Hilbert G, Gruson D, Varges F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344:481-487